Were talking about 0.5% to 1% volume effect 10 years down the road and that assumes quite significant adoption rates of the drug
#GLP1 #MetabolicHealth #BehaviorChange #HealthcareTrends #Wellness To view or add a comment, sign in A useful reminder that prevention often begins by paying closer attention to what appears ordinary
The session highlighted concerns that: Appetite suppression may mask eating disorder symptoms Weight loss may be misinterpreted as clinical improvement Binge eating disorder may be misdiagnosed, particularly in larger-bodied individuals It is necessary to emphasize the importance of careful screening and ongoing assessment
Its important that we dont have people taking GLP-1s or weight loss medication without primary care, she says
"A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3) - Lilly Clinical Trials"
Support Your Goals With a Semaglutide Compounding Pharmacy in Washington, DC for Weight Management Semaglutide has emerged as a promising option for those struggling with weight management, but access and affordability can be barriers